Status and barriers to circular bio-based building material adoption in developed economies: The case of Flanders, Belgium.

Circular bio-based building materials (CBBMs) provide a potential solution to reduce the climate impacts of buildings and offer opportunities to transition the construction industry to a circular model. Promoting the use of these materials can also bring economic, environmental, and social benefits from valorising biowaste and by-products from other sectors. Despite their potential, CBBMs have not received sufficient attention globally, and their adoption is hindered by various barriers. However, it is unclear what the CBBMs' use status is, what adoption barriers exist, how these barriers interact, and what should be done to address them. This study addresses these knowledge gaps through a systematic study using mixed methods to investigate the adoption status and barriers to these materials in developed economies by using a specific case analysis in Flanders. The data analysis results show that hemp-based, cork-based, and straw-based materials are the most used, while the market for CBBMs is very limited in the region. Twenty-three potential adoption barriers were identified and selected from the existing literature, then ranked based on their mean scores. The t-test analysis helps to identify 13 critical barriers, which are grouped into five categories, including cost and risk-related barriers, technical and cultural-related barriers, the government's role-related barriers, information and quality-related barriers, and market-related barriers. Among them, cost and risk-related barriers, including "concern about the high initial cost", "risks and uncertainties involved in adopting new materials", and "perception of the extra cost being incurred", are the three most critical barriers to CBBM adoption in Flanders. Kendall's W test shows good consensus among the two expert groups-with and without hands-on experience in utilising CBBMs-in their rankings of the barriers. Meanwhile, the Mann-Whitney U test indicates no statistically significant differences in the ranks of barriers between the two expert groups. The interview results confirm almost all survey results and provide deeper insights into the status and barriers to adopting these materials. Practical and policy implications are discussed based on these findings to inform policy deliberations on promoting CBBMs. This study may also be a good reference for scholars and industry practitioners to better understand issues impacting decision-making towards the adoption of CBBMs in the construction industry.

Exome sequencing data screening to identify undiagnosed Aromatic l-amino acid decarboxylase deficiency in neurodevelopmental disorders.

Aromatic l-amino acid decarboxylase (AADC) deficiency is a rare autosomal recessive neurometabolic disorder caused by biallelic pathogenic variants in the DDC gene and mainly characterized by developmental delay, hypotonia, and oculogyric crises. Early diagnosis is crucial for correct patient management; however, many patients remain misdiagnosed or undiagnosed due to the rarity and clinical heterogeneity of the disorder especially in the milder forms. Here, we applied exome sequencing approach by screening 2000 paediatric patients with neurodevelopmental disorders to identify possible new AADC variants and AADC deficiency patients. We identified five distinct DDC variants in two unrelated individuals. Patient #1 harboured two compound heterozygous DDC variants: c.436-12T > C and c.435 + 24A>C and presented with psychomotor delay, tonic spasms, and hyperreactivity. Patient #2 had three homozygous AADC variants: c.1385G > A; p.Arg462Gln, c.234C > T; p.Ala78 = , and c.201 + 37A > G and presented with developmental delay and myoclonic seizures. The variants were classified as benign class I variants and therefore non-causative according to the ACMG/AMP guidelines. Since the AADC protein is a structural and functional obligate homodimer, we evaluated the possible AADC polypeptide chain combinations in the two patients and determined the effects resulting from the amino acid substitution Arg462Gln. Our patients carrying DDC variants presented clinical manifestations not precisely overlapped to the classical symptoms exhibited by the most severe AADC deficiency cases. However, screening data derived from exome sequencing in patients featuring wide-range symptoms related to neurodevelopmental disorders may help to identify AADC deficiency patients, especially when applied to larger cohorts.

Estimating the material stock in wooden residential houses in Finland.

The aims of this study were to quantify the amount of wood in residential houses in Finland in 2017 that could be available for cascading, and to characterize the age distribution and gross floor area of the houses in the stock. Through a bottom-up material stock analysis, the mass of wood and the gross floor area of buildings in each building type and construction period were estimated. The study found that 10 million tons of wood are contained in the structures of residential houses built before 1969, equivalent to around 59% of the stock. Since much of this stock is nearing end of life, this material should soon become available for cascading so providing a significant potential resource. It was also found that, overall, the structural parts of residential houses embody 17.5 million tons of wood, of which around 9 million tons is, theoretically, reusable and recyclable. However, for effective reuse and recycling, further analysis of the quality, type and future availability of recovered wood is required. The current results could be used for material stock and flow analyses to help planning for the use of recovered wood. Further research is needed to fill in gaps in the time-series of the number and gross floor area of buildings constructed and their average gross floor area. Moreover, a material intensity analysis of Finnish buildings is needed to better quantify the wood used.